<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27770" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Proctitis and Anusitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Meseeha</surname>
            <given-names>Marcelle</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Attia</surname>
            <given-names>Maximos</given-names>
          </name>
          <aff>Guthrie/RPH Family Residency Program</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marcelle Meseeha declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maximos Attia declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27770.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Proctitis is inflammation of the rectal mucosa, distal to the rectosigmoid junction, within 18 cm of the anal verge. Anusitis is inflammation of the lining of the anal canal. Anusitis is a common disorder that is often misdiagnosed as hemorrhoids. This activity describes the pathophysiology and presentation of proctitis and anusitis and highlights the role of the interprofessional team in their management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the causes of anusitis and proctitis.</p></list-item><list-item><p>Describe the presentation of patient with anusitis and proctitis.</p></list-item><list-item><p>Review the treatment options for anusitis and proctitis.</p></list-item><list-item><p>Explain the importance of improving coordination amongst the interprofessional team to enhance care for patients affected by anusitis or proctitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27770&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27770">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27770.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Proctitis is inflammation of the rectal mucosa, distal to the rectosigmoid junction, within 18 cm of the anal verge. It&#x000a0;can be acute or chronic. Anusitis is inflammation of the lining of the anal canal. Anusitis is a common disorder that is rarely diagnosed and is often misdiagnosed as hemorrhoids.</p>
      </sec>
      <sec id="article-27770.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Proctitis and anusitis may happen secondary to ulcerative colitis (UC), Chronic Radiation Proctitis, Proctopathy (CRP), or Diversion Proctitis (DP). Infectious causes include Clostridium difficile, enteric infections (Campylobacter, Shigella, Escherichia coli, Salmonella, and amebiasis), and STI&#x02019;s (Gonorrhea, Chlamydia, Syphilis, HSV, Lymphogranuloma venereum, chancroid, CMV, HPV).<xref ref-type="bibr" rid="article-27770.r1">[1]</xref> Other causes include ischemia, vasculitis, toxins as hydrogen peroxide enemas or medication side effects. The most common cause of anusitis is diet, as with excess citrus, coffee, cola, beer, garlic, spices, and sauces. Diarrhea noted after intake of laxatives as in preparation for colonoscopy is noted to cause anusitis and stress may be another etiologic factor.</p>
      </sec>
      <sec id="article-27770.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Gonococcal and chlamydial proctitis and anusitis occur predominantly in young adults. Incidence is more in males than females. Gonococcal proctitis is most common in individuals younger than 25 years. Among men who have sex with men (MSM), prevalence rates of rectal chlamydia and rectal gonorrhea are 9% and 5% respectively. People of Jewish descent are 3-5 times more likely to develop UC and more than 30% of patients with UC have isolated rectal involvement. In children diagnosed with UC, 25% will only have ulcerative proctitis (UP). Girls are two times more likely to have UP than boys. Acute radiation proctitis and anusitis occur in the majority of patients, but are self-limited and last up to three months after the start of radiotherapy. CRP prevalence ranges from 2% to 20% and onset ranges from eight to 13 months but can occur many years after radiation exposure. DP onset is usually from three to 36 months after fecal diversion, and less than 50% of patients are symptomatic.</p>
      </sec>
      <sec id="article-27770.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In genetically predisposed individuals with dysregulated immune responses, GI infections may increase the risk of ulcerative proctitis (UP). Appendectomy and smoking appeared to act as protective factors from UP. CRP occurs secondary to ischemic and fibrotic changes. In the case of DP, proximal fecal diversion causes increased nitrate-reducing bacteria and decreased obligate anaerobes resulting in short-chain fatty acids deficiency. Rectal intercourse in women or MSM can result in proctocolitis. Radiation injury occurs with doses 8 Gy or higher causing damage to intestinal cell DNA with helical breaks and inability to replicate and undergo normal cellular repair.&#x000a0;</p>
      </sec>
      <sec id="article-27770.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Anorectal symptoms consistent with proctitis and anusitis include bloody or purulent discharge and pain on defecation, digital exam or during anal intercourse and pruritus as a common complaint in anusitis. LGV proctitis can be asymptomatic, mucoid and/or hemorrhagic rectal discharge, anal pain, constipation, fever, and/or tenesmus. Chronic proctitis presents with rectal bleeding, diarrhea, urgency, tenesmus, incontinence, or pelvic pain. UP presents with courses of remissions and relapses. Proctitis and anusitis secondary to radiation or inflammatory bowel diseases may show perianal abscesses, anal fissures or anal fistulae. Those due to STI&#x02019;s may show perianal or rectal ulcers, chancres, condyloma, or tender inguinal lymphadenopathy. IBD-associated/radiation proctitis present with anal fistula/fissures, perianal abscesses, rectal bleeding or guaiac-positive stools.</p>
      </sec>
      <sec id="article-27770.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial tests include anal examination or anoscopy for Gram-stained smear of anorectal exudates to check for polymorphonuclear leukocytes. Stool culture is used for E. coli O157:H7, Salmonella, Shigella, and amebiasis. Serological markers (p-ANCA, and ASCA) have low sensitivity in UP. STD testing include nucleic acid amplification test (NAAT) for <italic toggle="yes">Chlamydia trachomatis</italic>&#x000a0;and NAAT or culture for <italic toggle="yes">Neisseria gonorrhoeae</italic>. Polymerase chain reaction (PCR) is used to test HSV, LGV and C difficile toxin in stool. ELISA is used to test HIV, and darkfield and serologic testing are used for T. pallidum. STD-related proctitis indicates sexual abuse if found in infants or children. Diagnostic procedures include anoscopy, proctosigmoidoscopy and biopsy if there is suspicion for IBD. In CRP, endoscopic biopsies should be taken from the postero-lateral walls due to concerns about fistula formation.</p>
      </sec>
      <sec id="article-27770.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>When the presentation is consistent with acute proctitis in patients with receptive anal intercourse, therapy should be initiated while awaiting results of laboratory tests. Partners of patients with STI&#x02019;s should be evaluated and patients should refrain from sexual intercourse until they are treated. Gonococcal proctitis is treated with ceftriaxone 250 mg intramuscular one time plus azithromycin 1 gram oral one time. An alternative regimen is cefixime 400 mg oral one time plus doxycycline 100 mg oral twice daily for seven days. Chlamydia is treated with azithromycin. Doxycycline, erythromycin, ofloxacin or Levofloxacin may be used as an alternative regimen. LGV is treated with doxycycline 100 mg twice daily for 21 days. Erythromycin or azithromycin may be used as alternative regimens for the same period of 21 days. Herpes proctitis is treated with acyclovir 400 mg oral three times daily or valacyclovir 1 gram twice daily or famciclovir 250 mg three times daily for 7 to 10 days. The course of treatment may be extended if no complete healing is achieved by the end of the 10-day course of treatment.<xref ref-type="bibr" rid="article-27770.r2">[2]</xref><xref ref-type="bibr" rid="article-27770.r3">[3]</xref></p>
        <p>For patients with mild to moderate UP, guidelines from American College of Gastroenterology (ACG) and American Gastroenterological Association (AGA) recommend using rectal 5-Aminosalicylic Acid (5-ASA) mesalamine rather than oral mesalamine. Suppositories are more effective than enemas. For induction of remission, the dose is 1 g/day and this is to be continued at the same dose to maintain remission.&#x000a0; In cases of intolerance, refractoriness, hypersensitivity to mesalamine suppositories, inability to retain rectal therapy, rectal corticosteroid therapy is suggested for induction of remission rather than no therapy, despite the superiority of rectal 5-ASA over rectal steroids.&#x000a0; Corticosteroids are not recommended and are not effective in maintenance of remission secondary to side effects and long-term complications. Up to 46% of patients with UP may develop extensive colitis. This should be especially suspected in patients refractory to topical treatment and follow-up is recommended.<xref ref-type="bibr" rid="article-27770.r4">[4]</xref><xref ref-type="bibr" rid="article-27770.r5">[5]</xref></p>
        <p>UP is treated with topical mesalazine in the form of suppositories, enemas, foams and gels and in severe cases combined with oral mesalazine with topical steroids or systemic corticosteroids in more severe cases. In steroid resistant cases, the addition of cyclosporine or immunomodulators; thiopurines as azathioprine (AZA) and 6-mercaptopurine (6-MP) is considered. Other options include anti TNF-&#x003b1; (infliximab, adalimumab, and golimumab), anti-integrin antibodies&#x000a0;as vedolizumab and etrolizumab, or oral tacrolimus.<xref ref-type="bibr" rid="article-27770.r6">[6]</xref><xref ref-type="bibr" rid="article-27770.r7">[7]</xref></p>
        <p>For CRP, topical sucralfate enema is the best available treatment. For DP, topical short-chain fatty acids (SCFAs) enemas, topical 5-ASA, or topical steroids are used. In patients with intractable symptoms despite intensive therapy or complications including strictures, fistulas, and persistent bleeding, colostomy, ileostomy, proctectomy or proctocolectomy with ileal pouch&#x02013;anal anastomosis (IPAA) may be considered. The application of a cold retaining probe to the anal canal may give relief to anusitis patients as well as diet change and better handling of stress.<xref ref-type="bibr" rid="article-27770.r8">[8]</xref></p>
      </sec>
      <sec id="article-27770.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Anal fistulas</p>
          </list-item>
          <list-item>
            <p>Anal fissures</p>
          </list-item>
          <list-item>
            <p>Chancroid</p>
          </list-item>
          <list-item>
            <p>Clostridium difficile colitis</p>
          </list-item>
          <list-item>
            <p>Diverticulitis</p>
          </list-item>
          <list-item>
            <p>Herpes simplex</p>
          </list-item>
          <list-item>
            <p>Infectious bacterial or viral diarrhea</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Lymphogranuloma venereum</p>
          </list-item>
          <list-item>
            <p>Rectal foreign body</p>
          </list-item>
          <list-item>
            <p>Syphilis</p>
          </list-item>
          <list-item>
            <p>Traumatic proctitis</p>
          </list-item>
          <list-item>
            <p>Vulvovaginitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27770.s10" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Patient monitoring includes HCV screening which should be performed at least annually and more frequently depending on specific circumstances including STD-related proctitis. In chlamydial or gonococcal proctitis, retesting for the respective pathogen should be performed three months after treatment. Counsel about safe sex practices, including condom use during every sexual encounter is important. CRP is rarely curable.</p>
      </sec>
      <sec id="article-27770.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Proctitis and anusitis are best managed by an interprofessional team including nurses. There are many causes of proctitis and anusitis and it is important to determine the primary cause for the treatment to be effective. One should not alway assume that the cause if IBD, many infectious disorders can present in a similar fashion.</p>
        <p>For infectious causes, the outlook is good with treatment, but with IBD, recurrences are well known and significantly affect the quality of life.&#x000a0;</p>
      </sec>
      <sec id="article-27770.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27770&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27770">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/proctitis-and-anusitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27770">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27770/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27770">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27770.s13">
        <fig id="article-27770.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Colonoscopy of Radiation Proctitis, Moderate-to-Severe Contributed by Tdvorak, Wikimedia Commons, (CC by 2.0) https://creativecommons.org/licenses/by/2.0/</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Radiation_proctitis1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27770.s14">
        <title>References</title>
        <ref id="article-27770.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagdasarian</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Malani</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of Clostridium difficile in adults: a systematic review.</article-title>
            <source>JAMA</source>
            <year>2015</year>
            <month>Jan</month>
            <day>27</day>
            <volume>313</volume>
            <issue>4</issue>
            <fpage>398</fpage>
            <page-range>398-408</page-range>
            <pub-id pub-id-type="pmid">25626036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27770.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
            </person-group>
            <article-title>Sexually transmitted diseases treatment guidelines, 2015.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <day>05</day>
            <volume>64</volume>
            <issue>RR-03</issue>
            <fpage>1</fpage>
            <page-range>1-137</page-range>
            <pub-id pub-id-type="pmid">26042815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27770.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Vries</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Zingoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kreuter</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens.</article-title>
            <source>Int J STD AIDS</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>465</fpage>
            <page-range>465-74</page-range>
            <pub-id pub-id-type="pmid">24352129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27770.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubin</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Ananthakrishnan</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Sauer</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>ACG Clinical Guideline: Ulcerative Colitis in Adults.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>114</volume>
            <issue>3</issue>
            <fpage>384</fpage>
            <page-range>384-413</page-range>
            <pub-id pub-id-type="pmid">30840605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27770.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feuerstein</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Falck-Ytter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Falck-Ytter</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>RK</given-names>
              </name>
              <collab>American Gastroenterological Association Institute Clinical Guidelines Committee</collab>
            </person-group>
            <article-title>AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.</article-title>
            <source>Gastroenterology</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>156</volume>
            <issue>3</issue>
            <fpage>748</fpage>
            <page-range>748-764</page-range>
            <pub-id pub-id-type="pmid">30576644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27770.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kent</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Keshav</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Managing intractable proctitis and the problematic pouch.</article-title>
            <source>Dig Dis</source>
            <year>2014</year>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-37</page-range>
            <pub-id pub-id-type="pmid">24969291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27770.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hirai</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hida</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koyanagi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hibi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2012</year>
            <month>May</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>803</fpage>
            <page-range>803-8</page-range>
            <pub-id pub-id-type="pmid">21887732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27770.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>XR</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>703</fpage>
            <page-range>703-15</page-range>
            <pub-id pub-id-type="pmid">25687266</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
